LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

Home・Aktien・NeoGenomics Inc

NeoGenomics Inc

Geschlossen

7.87 -0.76

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

7.8

Max

7.95

Schlüsselkennzahlen
By Trading Economics
Einkommen	-19M -45M
Verkäufe	13M 181M
Gewinnspanne	-24.867
Angestellte	2,200
EBITDA	-41M -48M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+30.26% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	4. Nov. 2025

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	303M 1.1B
Vorheriger Eröffnungskurs	8.63
Vorheriger Schlusskurs	7.87

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

7.7 / 10.27 Unterstützung & Widerstand

NeoGenomics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

8. Sept. 2025, 17:01 UTC

Wichtige Markttreiber

Eightco Holdings Stock Surges as Dan Ives Joins Board Amid Crypto Push

8. Sept. 2025, 17:01 UTC

Wichtige Markttreiber

Tron Shares Rise After New Investment From Bravemorning

8. Sept. 2025, 15:14 UTC

Akquisitionen, Fusionen, Übernahmen

CoinShares to Go Public by Merging With SPAC

8. Sept. 2025, 13:58 UTC

Wichtige Markttreiber

Forward Industries Shares Jump After Private Investment for Solana

5. Sept. 2025, 14:58 UTC

Wichtige Markttreiber

Pineapple Financial Shares Rise After $100 Million Private Placement Closes

2. Sept. 2025, 16:52 UTC

Wichtige Markttreiber

CleanCore Solutions Shares Drop After $175 Million Private Investment

8. Sept. 2025, 16:16 UTC

Ergebnisse

Strategy Stock May Not Ever Make It Into the S&P 500 Index -- Barrons.com

8. Sept. 2025, 08:17 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8. Sept. 2025, 08:17 UTC

Market Talk

Bitcoin Falls as Traders Eye U.S. Inflation Data -- Market Talk

5. Sept. 2025, 16:39 UTC

Akquisitionen, Fusionen, Übernahmen

Yorkville Acquisition: Commencing at Market Open on Sept 8, Common Stk Will Trade on Nasdaq Under New Ticker Symbol 'MCGA' >YORK

5. Sept. 2025, 16:39 UTC

Akquisitionen, Fusionen, Übernahmen

Yorkville Acquisition: Will Be Renamed to Trump Media Group CRO Strategy Upon Closing of Combination Between Yorkville, Trump Media & Technology Group Corp. and Crypto.com >YORK

5. Sept. 2025, 16:39 UTC

Akquisitionen, Fusionen, Übernahmen

Yorkville Acquisition Corp.: Announces Ticker Symbol Change to 'MCGA' Ahead of Trump Media Group CRO Strategy, Inc. Listing

5. Sept. 2025, 16:39 UTC

Akquisitionen, Fusionen, Übernahmen

Yorkville Acquisition: Outstanding Publicly Traded Units and Warrants Will Trade on Nasdaq Under New Ticker Symbols 'MCGAU' and 'MCGAW', Respectively >YORK

5. Sept. 2025, 14:43 UTC

Wichtige Markttreiber

Pineapple Financial Shares Rise After $100M Private Placement Closes

5. Sept. 2025, 14:06 UTC

Akquisitionen, Fusionen, Übernahmen

Trump Media to Buy Cryptocurrency From Crypto.com In Deal Worth $104.7M

5. Sept. 2025, 07:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

5. Sept. 2025, 07:50 UTC

Market Talk

Bitcoin Rises to One-Week High Before U.S. Jobs Data -- Market Talk

4. Sept. 2025, 08:03 UTC

Market Talk

Bitcoin Becoming More Affected by U.S. Data -- Market Talk

4. Sept. 2025, 07:45 UTC

Market Talk

Bitcoin Edges Lower as Traders Eye U.S. Jobs Data, Tariff Uncertainty -- Market Talk

3. Sept. 2025, 09:18 UTC

Market Talk

Bitcoin Falls as Bond Market Selloff Dents Sentiment -- Market Talk

2. Sept. 2025, 16:37 UTC

Wichtige Markttreiber

CleanCore Solutions Shares Drop After $175M Private Investment

2. Sept. 2025, 13:25 UTC

Akquisitionen, Fusionen, Übernahmen

PharmaCyte Biotech Increased Stake in TNF by an Additional $3M >PMCB

2. Sept. 2025, 13:24 UTC

Akquisitionen, Fusionen, Übernahmen

PharmaCyte Biotech Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

2. Sept. 2025, 11:04 UTC

Akquisitionen, Fusionen, Übernahmen

Sharps Technology Acquires Over 2M SOL, the Native Asset of Solana

2. Sept. 2025, 07:31 UTC

Market Talk

Bitcoin Lifted by Fed Rate Cut Bets, Metaplanet Purchases -- Market Talk

1. Sept. 2025, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

1. Sept. 2025, 07:07 UTC

Market Talk

Bitcoin Falls to 2-Month Low After Tech Slump -- Market Talk

29. Aug. 2025, 07:16 UTC

Market Talk

Bitcoin Falls as Traders Digest Waller Remarks, Await PCE Data -- Market Talk

29. Aug. 2025, 07:16 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

28. Aug. 2025, 08:37 UTC

Market Talk

Bitcoin ETFs See Pickup in Demand -- Market Talk

Peer-Vergleich

Kursveränderung

NeoGenomics Inc Prognose

Kursziel

By TipRanks

30.26% Vorteil

12-Monats-Prognose

Durchschnitt 10.33 USD 30.26%

Hoch 14 USD

Tief 8 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für NeoGenomics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

11 ratings

Buy

Halten

Sell

Basierend auf 11 Analysten, die in den letzten 3 Monaten Aktienbewertungen für NeoGenomics Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

7.7 / 10.27Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

All events are bearish.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.